Progression and treatment rates using an active surveillance protocol incorporating image-guided baseline biopsies and multiparametric magnetic resonance imaging monitoring for men with favourable-risk prostate cancer

Author:

Thurtle David12,Barrett Tristan34,Thankappan-Nair Vineetha24,Koo Brendan34,Warren Anne45,Kastner Christof24,Saeb-Parsy Kasra24,Kimberley-Duffell Jenna6,Gnanapragasam Vincent J.1246

Affiliation:

1. Academic Urology Group; University of Cambridge; Cambridge UK

2. Department of Urology; Cambridge University Hospitals NHS Foundation Trust; Cambridge UK

3. Department of Radiology; Cambridge University Hospitals NHS Foundation Trust; Cambridge UK

4. CamPARI-Clinic Cambridge Prostate Cancer Service; University of Cambridge; Cambridge UK

5. Department of Pathology; Cambridge University Hospitals NHS Foundation Trust; Cambridge UK

6. Cambridge Urology, Translational Research and Clinical Trials; University of Cambridge; Cambridge UK

Publisher

Wiley

Subject

Urology

Reference35 articles.

1. Trends and outcome from radical therapy for primary non-metastatic prostate cancer in a UK population;Greenberg;PLoS One,2015

2. Radical prostatectomy versus observation for localized prostate cancer;Wilt;N Engl J Med,2012

3. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer;Hamdy;N Engl J Med,2016

4. NICE National Institute for Health and Care Excellence NICE Guidelines [CG175] Prostate cancer: diagnosis and treatment 2014

5. Active surveillance for low-risk localized prostate cancer;Large;Oncology (Williston Park),2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3